About Tecentriq 1200 mg Injection
Seize a hot deal on Tecentriq 1200 mg Injection, a splendid choice for advanced cancer care, now available at an unbeatable price. Proudly offered as a single-use vial, Tecentriq exemplifies noble innovation with its humanized IgG1 monoclonal antibody-atezolizumab-targeting PD-L1. Indicated for adults battling non-small cell lung cancer (NSCLC), urothelial carcinoma, and specific other malignancies, it is administered by healthcare professionals via intravenous infusion. Purchase this lavish treatment option, suitable solely on prescription, from leading exporters, suppliers, traders, and wholesalers across India. Store in a refrigerator, and experience up to 18 months of assured shelf life.
Applications & Usage: Versatile Cancer Therapy
Tecentriq 1200 mg Injection is most prominently used in the management of non-small cell lung cancer (NSCLC) and urothelial carcinoma. Under specialist guidance, it is also utilized for other eligible malignancies, broadening its splendid utility in modern oncology. Designed exclusively for intravenous use, Tecentriq should be administered by qualified healthcare professionals. It offers a tailored therapeutic option in adult patients, mirroring the ongoing advancement in personalized cancer care and targeted immunotherapy approaches.
Sample Availability & Reliable Logistics
Sample of Tecentriq 1200 mg Injection can be provided upon request, ensuring swift evaluation by healthcare institutions. Backed with essential certifications, this product meets international quality standards. Effortless handover and quick dispatch are assured through reliable transport services, making distribution across the main domestic market seamless. Professional exporters, suppliers, and wholesalers in India ensure timely delivery, prioritizing integrity and efficacy throughout the transport process to maintain the highest pharmaceutical standards.
FAQ's of Tecentriq 1200 mg Injection:
Q: How is Tecentriq 1200 mg Injection administered?
A: Tecentriq 1200 mg Injection is administered intravenously by a healthcare professional in a medical facility, following a physician's prescription and guidance.
Q: What are the primary uses of Tecentriq 1200 mg Injection?
A: Tecentriq is primarily used to treat adults with non-small cell lung cancer (NSCLC), urothelial carcinoma, and select other cancers as determined by medical professionals.
Q: When should Tecentriq not be used?
A: Tecentriq is contraindicated in individuals with known hypersensitivity to atezolizumab or its excipients. Consult your healthcare provider for a full list of contraindications.
Q: Where should Tecentriq 1200 mg Injection be stored?
A: Tecentriq must be stored in a refrigerator at 2C to 8C, protected from light, and should never be frozen to maintain its efficacy.
Q: What is the process for acquiring Tecentriq 1200 mg Injection samples?
A: Interested institutions or healthcare providers can request a sample, which will be promptly dispatched and handed over using efficient transport services by certified suppliers.
Q: What are common side effects associated with Tecentriq?
A: The most reported side effects include fatigue, nausea, decreased appetite, cough, difficulty breathing, and various immune-mediated reactions. Medical supervision is essential during its administration.